CELL & GENE THERAPY event

Novartis has recently announced its intent to invest up to 90 million Swiss francs to build a production facility for innovative cell and gene therapies in Stein in the canton of Aargau. What does this mean for Switzerland's research landscape? And how can the United Kingdom profit from this? We are bringing the UK- and Swiss-based ecosystems together for a joint discussion on current key topics with regards to R&D, business opportunities and future ambitions. Join us for an afternoon filled with exciting presentations and networking opportunities in one of the world's most prestigious Universities.

Welcome

15:00

Ms. Natalie Thomas

Head of the Swiss Business Hub UK + Ireland

Welcome Address

15:05

Mr. Markus Leitner

Ambassador of Switzerland to the United Kingdom

Welcome Address

15:10

Mr. George Freeman MP (TBC)

UK Minister of Science, Research & Innovation

Presentation: Stevenage Life Sciences research and R&D cluster

15:20

Ms. Kasia Averall

Head of Cluster Development at Cell and Gene Therapy Catapult

Presentation: The UK Cell & Gene Therapy ecosystem

15:40

Prof. Cedric Ghevaert

Cambridge Stem Cell Institute & Consultant Haemotologist for NHS Blood and Transplant

Presentation: The Swiss Cell & Gene Therapy ecosystem

16:00

Prof. Dr. Simon P. Hoerstrup

Chair & Director at Institute for Regenerative Medicine (IREM), Founding Co-Director at Wyss Translational Center Zurich, University of Zurich and ETH Zurich

Break

16:20

Presentation: How to start Cell & Gene Therapies in Switzerland

16:35

Dr. George Coukos

Director of Oncology University Hospital of Lausanne & Branch Director at Ludwig Cancer Research

Panel Discussion: Common challenges in introducing Cell & Gene Therapies

16:45

Moderator:

Dr. Kristin-Anne Rutter

Executive Director at the University of Cambridge

 

Dr. Stephen Ward

Chief Manufacturing Officer at The Cell and Gene Therapy Catapult

Dr. Corinne Solier

COO at Scailyte

Dr. George Coukos

Director of Oncology University Hospital of Lausanne & Branch Director at Ludwig Cancer Research

Dr. Mark Kotter

Founder & CEO of bit.bio and Stem Cell Biologist at the University of Cambridge

Dr. Anna Williamson

Executive Director, Business Development & Head of UK Business Development at Roche / Genentech

Closing Remarks

17:45

Prof. Patrick Maxwell

Regius Professor of Physic and Head of the School of Clinical Medicine at the University of Cambridge

Drinks Reception

17:50

VIP Dinner

19:00

Trinity College, University of Cambridge

Invitation only 

Looking for something specific?